About 43,000 results
Open links in new tab
  1. Tardive Dyskinesia (TD) | AUSTEDO XR® (deutetrabenazine) …

    AUSTEDO XR ® (deutetrabenazine) extended-release tablets and AUSTEDO ® (deutetrabenazine) tablets are indicated in adults for the treatment of chorea associated with …

  2. AUSTEDO XR® Medication for Tardive Dyskinesia (TD)

    Once-daily AUSTEDO XR® (deutetrabenazine) extended release tablets reduce uncontrollable Tardive Dyskinesia (TD) body movements. See safety info including Boxed Warning.

  3. Austedo (deutetrabenazine): Uses, Side Effects, Dosage Guide

    Aug 20, 2025 · Austedo's drug class is a VMAT2 inhibitor (vesicular monoamine transporter 2 inhibitor). Austedo tablets are taken twice daily, and the Austedo XR (extended-release) …

  4. Deutetrabenazine Tablets Improve Tardive Dyskinesia Symptoms

    Oct 22, 2025 · She added, “These data articulate patient experience and further validate clinical research showing how AUSTEDO or AUSTEDO XR can help people living with tardive …

  5. Phase 4 Data Support Effectiveness of Deutetrabenazine in …

    Nov 26, 2025 · Teva Pharmaceuticals announced data from the ongoing real-world phase 4 study, coined IMPACT-TD Registry, evaluating the efficacy of deutetrabenazine (Austedo) …

  6. Austedo Phase 4 Data Shows Reduction in Tardive Dyskinesia

    Nov 12, 2025 · Austedo standard and XR tablets are currently indicated for adults for the treatment of chorea in Huntington disease and tardive dyskinesia. Austedo is the first VMAT2 …

  7. AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR ...

    4 days ago · The most common adverse reactions for AUSTEDO (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis and …

  8. What is the FDA-Approved Treatment for Tardive Dyskinesia?

    Nov 26, 2025 · Learn about the FDA-approved treatment for tardive dyskinesia, specifically the VMAT2 inhibitors valbenazine (Ingrezza) and deutetrabenazine (Austedo).

  9. Austedo for Uncontrolled Movements in Huntington’s and Tardive Dyskinesia

    Austedo (aw-STED-oh) was approved in 2017 and is the first medicine approved to treat both tardive dyskinesia and chorea caused by Huntington’s disease.

  10. Tardive Dyskinesia Treatment | AUSTEDO XR® (deutetrabenazine)

    Reduce involuntary movements with AUSTEDO XR® (deutetrabenazine) tablets treatment for TD. See safety info and boxed warning.